{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:57:37Z","timestamp":1790704657267,"version":"4.1.0"},"reference-count":30,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br. J. Hosp. Med. (Lond)"],"abstract":"<jats:p>Aims\/Background: Diabetic kidney disease (DKD) is among the most prevalent complications of diabetes and is commonly accompanied by hypertension as a comorbid condition. The coexistence of these two conditions markedly augments the risk of cardiovascular disease. Although traditional risk factors such as dyslipidemia, smoking, and decreased renal function have been shown to be associated with increased cardiovascular events, evidence for the higher-risk subgroup of \u201cDKD with hypertension\u201d remains relatively limited. This study aimed to retrospectively analyze the influencing factors of adverse cardiovascular events in this population and assess the independent predictive value of different clinical indicators. Methods: In this single-center retrospective cohort study, 204 patients diagnosed with DKD and hypertension were enrolled between January 2021 and January 2024. Baseline data, including patient demographics and clinical indicators, were collected. Patients were divided into an event group and a non-event group based on whether they experienced cardiovascular events during the 12-month follow-up period. Independent risk factors were screened using univariate and multivariate logistic regression, and the effects of prior hyperlipidemia and smoking on event-free survival were assessed using Kaplan\u2013Meier curves. Results: Compared with the non-event group, patients in the event group had significantly higher levels of low-density lipoprotein (LDL), urinary protein, and kidney injury molecule-1 (KIM-1), and significantly lower levels of high-density lipoprotein (HDL), along with a greater prevalence of prior hyperlipidemia and smoking (all p &lt; 0.05). Univariate analysis showed that prior hyperlipidemia, smoking, elevated LDL, reduced HDL, and increased KIM-1 were all associated with cardiovascular events. Further multivariate analysis confirmed that prior hyperlipidemia, smoking, HDL, LDL, and KIM-1 were all independent predictors of cardiovascular events (all p &lt; 0.05). According to Kaplan\u2013Meier curve analysis, patients with a history of hyperlipidemia and a smoking habit had significantly lower event-free survival than those without these characteristics (p = 0.034 and p = 0.024). Conclusion: In DKD patients with hypertension, prior hyperlipidemia, smoking, elevated LDL, reduced HDL, and increased KIM-1 were key independent risk factors for cardiovascular events. The adverse association of dyslipidemia and smoking with event-free survival was evident early in the follow-up period. These results suggest that this high-risk population should receive enhanced lipid management and smoking cessation interventions, and the potential value of renal tubular injury markers (such as KIM-1) in cardiovascular risk assessment should be investigated to facilitate early identification of high-risk individuals and the development of individualized prevention strategies.<\/jats:p>","DOI":"10.31083\/bjhm49746","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:59:52Z","timestamp":1790701192000},"source":"Crossref","is-referenced-by-count":0,"title":["Risk Factor Analysis of Cardiovascular Events in Patients With Diabetic Kidney Disease and Hypertension: A Retrospective Study"],"prefix":"10.31083","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2803-3866","authenticated-orcid":true,"given":"Xiaofen","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Renal Endocrinology, The 943 Hospital of the Joint Logistics Support Unit of the Chinese People\u2019s Liberation Army, 733000 Wuwei, Gansu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Renal Endocrinology, The 943 Hospital of the Joint Logistics Support Unit of the Chinese People\u2019s Liberation Army, 733000 Wuwei, Gansu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duoqiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Renal Endocrinology, The 943 Hospital of the Joint Logistics Support Unit of the Chinese People\u2019s Liberation Army, 733000 Wuwei, Gansu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Renal Endocrinology, The 943 Hospital of the Joint Logistics Support Unit of the Chinese People\u2019s Liberation Army, 733000 Wuwei, Gansu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Gupta S, Dominguez M, Golestaneh L. Diabetic Kidney Disease: An Update. The Medical Clinics of North America. 2023; 107: 689\u2013705.","DOI":"10.1016\/j.mcna.2023.03.004"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Hoogeveen EK. The epidemiology of diabetic kidney disease. Kidney and Dialysis. 2022; 2: 433\u2013442.","DOI":"10.3390\/kidneydial2030038"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Kaur A, Sharma GS, Kumbala DR. Acute kidney injury in diabetic patients: A narrative review. Medicine. 2023; 102: e33888.","DOI":"10.1097\/MD.0000000000033888"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Sundstr\u00f6m J, Bodegard J, Bollmann A, Vervloet MG, Mark PB, Karasik A, et al. Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2\u00b74 million patients from 11 countries: The CaReMe CKD study. The Lancet Regional Health. Europe. 2022; 20: 100438.","DOI":"10.1016\/j.lanepe.2022.100438"},{"key":"ref5","unstructured":"Magliano DJ, Boyko EJ. IDF diabetes atlas. 10th edn. International Diabetes Federation: Brussels. 2021."},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Hubbard D, Colantonio LD, Rosenson RS, Brown TM, Jackson EA, Huang L, et al. Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease. Cardiovascular Diabetology. 2021; 20: 58.","DOI":"10.1186\/s12933-021-01247-0"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Sinha SK, Nicholas SB. Pathomechanisms of Diabetic Kidney Disease. Journal of Clinical Medicine. 2023; 12: 7349.","DOI":"10.3390\/jcm12237349"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Zha D, Gao P, Wu X. Role of Metabolic Abnormalities During the Progression of Chronic Kidney Disease and Preventive Strategies. International Journal of Medical Sciences. 2025; 22: 3543\u20133555.","DOI":"10.7150\/ijms.114382"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Wang Y, Jin M, Cheng CK, Li Q. Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives. Frontiers in Endocrinology. 2023; 14: 1238927.","DOI":"10.3389\/fendo.2023.1238927"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Wei Z, Wang F, Zhang L, Dai W. Clinical Efficacy of Ezetimibe Combined with Rosuvastatin in the Treatment of Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Therapy. British Journal of Hospital Medicine. 2024; 85: 1\u201313.","DOI":"10.12968\/hmed.2024.0457"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Roy S, Schweiker-Kahn O, Jafry B, Masel-Miller R, Raju RS, O'Neill LMO, et al. Risk Factors and Comorbidities Associated with Diabetic Kidney Disease. Journal of Primary Care & Community Health. 2021; 12: 21501327211048556.","DOI":"10.1177\/21501327211048556"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Jia G, Sowers JR. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension. 2021; 78: 1197\u20131205.","DOI":"10.1161\/HYPERTENSIONAHA.121.17981"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Banerjee D, Winocour P, Chowdhury TA, De P, Wahba M, Montero R, et al. Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021. BMC Nephrology. 2022; 23: 9.","DOI":"10.1186\/s12882-021-02587-5"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Kim Y, Kim W, Kim JK, Moon JY, Park S, Park CW, et al. Blood Pressure Control in Patients with Diabetic Kidney Disease. Electrolyte & Blood Pressure: E & BP. 2022; 20: 39\u201348.","DOI":"10.5049\/EBP.2022.20.2.39"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Ruhe J, Nadal J, B\u00e4rthlein B, Meiselbach H, Schultheiss UT, Kotsis F, et al. Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease-prospective data from the German Chronic Kidney Disease cohort. Clinical Kidney Journal. 2023; 16: 2032\u20132040.","DOI":"10.1093\/ckj\/sfad194"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Scilletta S, Di Marco M, Miano N, Filippello A, Di Mauro S, Scamporrino A, et al. Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk. Biomolecules. 2023; 13: 752.","DOI":"10.3390\/biom13050752"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Maqbool M, Cooper ME, Jandeleit-Dahm KAM. Cardiovascular Disease and Diabetic Kidney Disease. Seminars in Nephrology. 2018; 38: 217\u2013232.","DOI":"10.1016\/j.semnephrol.2018.02.003"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Chen SC, Tseng CH. Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients. The Review of Diabetic Studies: RDS. 2013; 10: 88\u2013100.","DOI":"10.1900\/RDS.2013.10.88"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"McDonnell T, Kalra PA. Iron in Chronic Kidney Disease and End-Stage Kidney Disease\u2014Current Trends and Future Direction. British Journal of Hospital Medicine. 2025; 86: 1\u201319.","DOI":"10.12968\/hmed.2024.0619"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco AL, De Jong PE, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2013; 3: 1\u2013150.","DOI":"10.1038\/kisup.2012.73"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020; 75: 1334\u20131357.","DOI":"10.1161\/HYPERTENSIONAHA.120.15026"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Annals of Internal Medicine. 2009; 150: 604\u2013612.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Li J, Shi L, Zhao G, Sun F, Nie Z, Ge Z, et al. High triglyceride levels increase the risk of diabetic microvascular complications: a cross-sectional study. Lipids in Health and Disease. 2023; 22: 109.","DOI":"10.1186\/s12944-023-01873-5"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Lui DTW, Tan KCB. High-density lipoprotein in diabetes: Structural and functional relevance. Journal of Diabetes Investigation. 2024; 15: 805\u2013816.","DOI":"10.1111\/jdi.14172"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Poochanasri M, Lertsakulbunlue S, Kookanok C, Rangsin R, Kaewput W, Mungthin M, et al. Triglyceride to high-density lipoprotein ratio as a predictor for 10-year cardiovascular disease in individuals with diabetes in Thailand. Journal of Health, Population, and Nutrition. 2025; 44: 147.","DOI":"10.1186\/s41043-025-00835-0"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Yu D, Wang Z, Zhang X, Qu B, Cai Y, Ma S, et al. Remnant Cholesterol and Cardiovascular Mortality in Patients With Type 2 Diabetes and Incident Diabetic Nephropathy. The Journal of Clinical Endocrinology and Metabolism. 2021; 106: 3546\u20133554.","DOI":"10.1210\/clinem\/dgab533"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Kourtidou C, Stangou M, Marinaki S, Tziomalos K. Novel Cardiovascular Risk Factors in Patients with Diabetic Kidney Disease. International Journal of Molecular Sciences. 2021; 22: 11196.","DOI":"10.3390\/ijms222011196"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Ren J, Liu D, Li G, Duan J, Dong J, Liu Z. Prediction and Risk Stratification of Cardiovascular Disease in Diabetic Kidney Disease Patients. Frontiers in Cardiovascular Medicine. 2022; 9: 923549.","DOI":"10.3389\/fcvm.2022.923549"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Kishi S, Nagasu H, Kidokoro K, Kashihara N. Oxidative stress and the role of redox signalling in chronic kidney disease. Nature Reviews. Nephrology. 2024; 20: 101\u2013119.","DOI":"10.1038\/s41581-023-00775-0"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Tonkonogi A, Carlsson AC, Helmersson-Karlqvist J, Larsson A, \u00c4rnl\u00f6v J. Associations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes. Upsala Journal of Medical Sciences. 2016; 121: 174\u2013178.","DOI":"10.1080\/03009734.2016.1192704"}],"container-title":["British Journal of Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/9\/10.31083\/BJHM49746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:00:52Z","timestamp":1790701252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/9\/10.31083\/BJHM49746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1759-7390(26)04030-0"],"URL":"https:\/\/doi.org\/10.31083\/bjhm49746","relation":{},"ISSN":["1750-8460","1759-7390"],"issn-type":[{"value":"1750-8460","type":"print"},{"value":"1759-7390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"49746"}}